Concert Pharmaceuticals
Why Robinhood?
You can watch CNCE and buy or sell other stocks, ETFs, and their options commission-free!About CNCE
Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders.
CNCE Key Statistics
Stock Snapshot
The current Concert Pharmaceuticals(CNCE) stock price is $8.37, with a market capitalization of 401.95M. The stock trades at a price-to-earnings (P/E) ratio of -2.61.
Concert Pharmaceuticals(CNCE) stock opened on 2026-03-12 at —. The price climbed to — and dipped to —.
Concert Pharmaceuticals(CNCE) shares are trading with a volume of 0, against a daily average of 2.51M.
During the past year, Concert Pharmaceuticals(CNCE) stock moved between $2.66 at its lowest and $8.55 at its peak.
During the past year, Concert Pharmaceuticals(CNCE) stock moved between $2.66 at its lowest and $8.55 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.